The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, J. S. H.
Right arrow Articles by Lee, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, J. S. H.
Right arrow Articles by Lee, S. C.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 1998, 161: 1989-1996.
Copyright © 1998 by The American Association of Immunologists

IFNs Are Critical Regulators of IL-1 Receptor Antagonist and IL-1 Expression in Human Microglia1

Judy S. H. Liu, Terry D. Amaral, Celia F. Brosnan and Sunhee C. Lee2

Department of Pathology (Neuropathology), Albert Einstein College of Medicine, Bronx, NY 10461

Because IL-1 is implicated in the pathogenesis of multiple sclerosis, and IFNs are known to alter disease course, we sought to determine whether IFNs can regulate the expression of IL-1 and IL-1R antagonist (IL-1Ra) in primary cultures of human microglia and astrocytes. We found that IL-1 and IL-1Ra are products of microglia but not astrocytes, and IFN-ß and IFN-{gamma} differentially modulate LPS- and cytokine-induced IL-1 and IL-1Ra. IFN-ß induces IL-1Ra and augments LPS- and IL-4-induced IL-1Ra, but suppresses LPS- and IL-1-induced IL-1, shifting the balance toward the expression of the IL-1Ra. Like IFN-ß, IFN-{gamma} suppresses the expression of both LPS and IL-1-induced IL-1ß. However, IFN-{gamma} also suppresses the expression of IFN-ß- and IL-4-induced IL-1Ra so that IFN-{gamma} may enhance or suppress IL-1 activity depending on the other cytokines present. IL-4 has similar effects to IFN-ß; however, other anti-inflammatory cytokines, did not regulate IL-1 or IL-1Ra in human microglia. Our data demonstrate a novel suppressive effect of IFN-ß and IL-4 on IL-1 activity in human microglia, suggesting that IFN-ß, a therapeutic agent used for multiple sclerosis, could have wider applications in the treatment of other central nervous system disorders in which IL-1 activity has been implicated in the pathogenesis.




This article has been cited by other articles:


Home page
J. Virol.Home page
H.-S. Suh, M.-L. Zhao, M. Rivieccio, S. Choi, E. Connolly, Y. Zhao, O. Takikawa, C. F. Brosnan, and S. C. Lee
Astrocyte Indoleamine 2,3-Dioxygenase Is Induced by the TLR3 Ligand Poly(I:C): Mechanism of Induction and Role in Antiviral Response
J. Virol., September 15, 2007; 81(18): 9838 - 9850.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q. Si, M.-L. Zhao, A. C. A. Morgan, C. F. Brosnan, and S. C. Lee
15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits IFN-Inducible Protein 10/CXC Chemokine Ligand 10 Expression in Human Microglia: Mechanisms and Implications
J. Immunol., September 1, 2004; 173(5): 3504 - 3513.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
G Palmer, F Mezin, C E Juge-Aubry, C Plater-Zyberk, C Gabay, and P-A Guerne
Interferon {beta} stimulates interleukin 1 receptor antagonist production in human articular chondrocytes and synovial fibroblasts
Ann Rheum Dis, January 1, 2004; 63(1): 43 - 49.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
G. R. John, S. C. Lee, and C. F. Brosnan
Cytokines: Powerful Regulators of Glial Cell Activation
Neuroscientist, February 1, 2003; 9(1): 10 - 22.
[Abstract] [PDF]


Home page
J Child NeurolHome page
S. Haspolat, B. Anlar, G. Kose, M. Coskun, and O. Yegin
Interleukin-1{beta}, Interleukin-1 Receptor Antagonist Levels in Patients With Subacute Sclerosing Panencephalitis and the Effects of Different Treatment Protocols
J Child Neurol, June 1, 2001; 16(6): 417 - 420.
[Abstract] [PDF]


Home page
NeurologyHome page
T. Kumpfel, F. T. Bergh, T. Pollmacher, F. Holsboer, and C. Trenkwalder
Acute effects of interferon beta-1a on plasma cytokine levels in patients with MS
Neurology, October 24, 2000; 55(8): 1231 - 1233.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. S. H. Liu, G. R. John, A. Sikora, S. C. Lee, and C. F. Brosnan
Modulation of Interleukin-1beta and Tumor Necrosis Factor alpha Signaling by P2 Purinergic Receptors in Human Fetal Astrocytes
J. Neurosci., July 15, 2000; 20(14): 5292 - 5299.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Hu, H. Ali, W. S. Sheng, L. C. Ehrlich, P. K. Peterson, and C. C. Chao
Gp-41-Mediated Astrocyte Inducible Nitric Oxide Synthase mRNA Expression: Involvement of Interleukin-1beta Production by Microglia
J. Neurosci., August 1, 1999; 19(15): 6468 - 6474.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. L. Reznikov, S.-H. Kim, J. Y. Westcott, J. Frishman, G. Fantuzzi, D. Novick, M. Rubinstein, and C. A. Dinarello
IL-18 binding protein increases spontaneous and IL-1-induced prostaglandin production via inhibition of IFN-gamma
PNAS, February 29, 2000; 97(5): 2174 - 2179.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.